Can G. Leineweber, Can G. Leineweber, Can G. Leineweber, Miriam Rabehl, Miriam Rabehl, Anne Pietzner, . . . Julia Benckert. (2024). Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma. Frontiers Media S.A..
Chicago Style (17th ed.) CitationCan G. Leineweber, et al. Corrigendum: Sorafenib Increases Cytochrome P450 Lipid Metabolites in Patient with Hepatocellular Carcinoma. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationCan G. Leineweber, et al. Corrigendum: Sorafenib Increases Cytochrome P450 Lipid Metabolites in Patient with Hepatocellular Carcinoma. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.